Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Naunyn Schmiedebergs Arch Pharmacol
2014 Dec 01;38712:1153-61. doi: 10.1007/s00210-014-1045-6.
Show Gene links
Show Anatomy links
Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.
Xynogalos P, Seyler C, Scherer D, Koepple C, Scholz EP, Thomas D, Katus HA, Zitron E.
???displayArticle.abstract???
Dronedarone is a novel class III antiarrhythmic drug that is widely used in atrial fibrillation. It has been shown in native cardiomyocytes that dronedarone inhibits cardiac inwardly rectifying current IK1 at high concentrations, which may contribute both its antifibrillatory efficacy and its potential proarrhythmic side effects. However, the underlying mechanism has not been studied in further detail to date. In the mammalian heart, heterotetrameric assembly of Kir2.x channels is the molecular basis of IK1 current. Therefore, we studied the effects of dronedarone on wild-type and mutant Kir2.x channels in the Xenopus oocyte expression system. Dronedarone inhibited Kir2.1 currents but had no effect on Kir2.2 or Kir2.3 currents. Onset of block was slow but completely reversible upon washout. Blockade of Kir2.1 channels did not exhibit strong voltage dependence or frequency dependence. In a screening with different Kir2.1 mutants lacking specific binding sites within the cytoplasmic pore region, we found that residue E224 is essential for binding of dronedarone to Kir2.1 channels. In conclusion, direct block of Kir2.1 channel subunits by dronedarone through binding at E224 may underlie its inhibitory effects on cardiac IK1 current.
Amorós,
Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
2013, Pubmed
Amorós,
Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
2013,
Pubmed Bosch,
Ionic mechanisms of electrical remodeling in human atrial fibrillation.
1999,
Pubmed Bosch,
Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes.
1999,
Pubmed Connolly,
Dronedarone in high-risk permanent atrial fibrillation.
2011,
Pubmed Danelich,
Clinical update on the management of atrial fibrillation.
2013,
Pubmed de Boer,
The anti-protozoal drug pentamidine blocks KIR2.x-mediated inward rectifier current by entering the cytoplasmic pore region of the channel.
2010,
Pubmed Dhamoon,
The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis.
2005,
Pubmed Dobrev,
Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.
2001,
Pubmed Du,
Characteristic interactions with phosphatidylinositol 4,5-bisphosphate determine regulation of kir channels by diverse modulators.
2004,
Pubmed
,
Xenbase Ferrer,
Carvedilol inhibits Kir2.3 channels by interference with PIP₂-channel interaction.
2011,
Pubmed Gautier,
Electrophysiologic characterization of dronedarone in guinea pig ventricular cells.
2003,
Pubmed Girmatsion,
Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.
2009,
Pubmed Hilgemann,
Cytoplasmic ATP-dependent regulation of ion transporters and channels: mechanisms and messengers.
1997,
Pubmed Hohnloser,
Effect of dronedarone on cardiovascular events in atrial fibrillation.
2009,
Pubmed Logothetis,
Diverse Kir modulators act in close proximity to residues implicated in phosphoinositide binding.
2007,
Pubmed Lopes,
Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies.
2002,
Pubmed
,
Xenbase López-Izquierdo,
Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.
2011,
Pubmed López-Izquierdo,
The antimalarial drug mefloquine inhibits cardiac inward rectifier K+ channels: evidence for interference in PIP2-channel interaction.
2011,
Pubmed Madeja,
Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis.
1997,
Pubmed
,
Xenbase Melnyk,
Differential distribution of Kir2.1 and Kir2.3 subunits in canine atrium and ventricle.
2002,
Pubmed Noujaim,
Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine.
2011,
Pubmed Noujaim,
Up-regulation of the inward rectifier K+ current (I K1) in the mouse heart accelerates and stabilizes rotors.
2007,
Pubmed Noujaim,
Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets.
2010,
Pubmed Ponce-Balbuena,
Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
2009,
Pubmed Preisig-Müller,
Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome.
2002,
Pubmed
,
Xenbase Rodríguez-Menchaca,
The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel.
2008,
Pubmed Rohács,
Specificity of activation by phosphoinositides determines lipid regulation of Kir channels.
2003,
Pubmed
,
Xenbase Sato,
Amiodarone blocks the inward rectifier potassium channel in isolated guinea pig ventricular cells.
1994,
Pubmed Schimpf,
Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis.
2005,
Pubmed Schimpf,
Short QT syndrome.
2005,
Pubmed Schram,
Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents.
2003,
Pubmed
,
Xenbase Singh,
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
2007,
Pubmed Thomas,
Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels.
2003,
Pubmed
,
Xenbase Tristani-Firouzi,
Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
2010,
Pubmed Tristani-Firouzi,
Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
2002,
Pubmed
,
Xenbase Van Wagoner,
Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation.
1997,
Pubmed Varró,
Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone.
2001,
Pubmed Voigt,
Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.
2010,
Pubmed Wang,
Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle.
1998,
Pubmed Xia,
A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation.
2005,
Pubmed Xie,
Phosphatidylinositol-4,5-bisphosphate (PIP2) regulation of strong inward rectifier Kir2.1 channels: multilevel positive cooperativity.
2008,
Pubmed
,
Xenbase Zaritsky,
Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation.
2000,
Pubmed Zobel,
Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir2.2.
2003,
Pubmed
